Aptiv PLC is rated as a 'Buy' with a $90 per share price target, suggesting it is undervalued at an 8x price-to-earnings ratio and could deliver a 20% annualized return. However, the company faces challenges including margin compression, volatile end markets, and risks related to its Versigent spin-off. Its future growth is heavily dependent on software development and electric vehicle adoption. Despite revenue growth, Aptiv struggles with declining margins, weak cash flow, and reliance on Chinese original equipment manufacturers. Alternatives like Autoliv and Magna offer similar upside potential but with dividends and stronger balance sheets, making them potentially better investment choices.
